Klin Onkol 2015; 28(6): 455-456.
Authors: Kulhavý Jan2015-12-15:Zpráva z European Cancer Congress 2015 Studie RADIANT-4 – trojnásobné prodloužení doby do progrese u plicních a gastrointestinálních neuroendokrinních nádorů
Authors: Kulhavý Jan2015-12-15:Zpráva z European Cancer Congress 2015 Studie RADIANT-4 – trojnásobné prodloužení doby do progrese u plicních a gastrointestinálních neuroendokrinních nádorů
Klin Onkol 2015; 28(6): 458-460.
Authors: Srbová Eva2015-12-15:Zpráva z European Cancer Congress 2015 Celkové přežití u nemalobuněčného karcinomu plic – přenos poznatků ze studií do praxe
Authors: Srbová Eva2015-12-15:Zpráva z European Cancer Congress 2015 Celkové přežití u nemalobuněčného karcinomu plic – přenos poznatků ze studií do praxe
Klin Onkol 2015; 28(6): 462-463.
Authors: Halámková Jana2015-12-15:Aktuality z odborného tisku
Authors: Halámková Jana2015-12-15:Aktuality z odborného tisku
Klin Onkol 2015; 28(6): 464-465.
Authors: Pešek Miloš2015-12-15:Dopis redakci časopisu Klinická onkologie
Authors: Pešek Miloš2015-12-15:Dopis redakci časopisu Klinická onkologie
Klin Onkol 2015; 28(6): 467.
Authors: Nenutil Rudolf2015-12-15:Prof. MUDr. Aleš Rejthar, CSc. (1938– 2015)
Authors: Nenutil Rudolf2015-12-15:Prof. MUDr. Aleš Rejthar, CSc. (1938– 2015)
Klin Onkol 2015; 28(6): 469-470.
Authors: Fabián Pavel2015-12-15:Onkologie v obrazech. Kolizní duplicitní nádory
Authors: Fabián Pavel2015-12-15:Onkologie v obrazech. Kolizní duplicitní nádory
Klin Onkol 2015; 28(6): 470.
2015-12-15:Informace z České onkologické společnosti
2015-12-15:Informace z České onkologické společnosti
Klin Onkol 2015; 28(Suppl 3): 3.
Authors: Trněný Marek, Smolej Lukáš, Doubek Michael2015-10-15:Editorial
Authors: Trněný Marek, Smolej Lukáš, Doubek Michael2015-10-15:Editorial
Klin Onkol 2015; 28(Suppl 3): 6-15.
DOI: 10.14735/amko20153S6.
Keywords: chronic lymphocytic leukemia – biological markers – chromosome aberations – mutations – prognosis
Authors: Navrkalová Veronika, Kantorová Iva, Jarošová Marie, Pospíšilová Šárka2015-10-15:Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – biological markers – chromosome aberations – mutations – prognosis
Authors: Navrkalová Veronika, Kantorová Iva, Jarošová Marie, Pospíšilová Šárka2015-10-15:Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 16-21.
DOI: 10.14735/amko20153S16.
Keywords: chronic lymphocytic leukemia – minimal residual disease – prognostic factors – fl ow cytometry – progression-free survival
Authors: Doubek Michael2015-10-15:Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – minimal residual disease – prognostic factors – fl ow cytometry – progression-free survival
Authors: Doubek Michael2015-10-15:Significance of Minimal Residual Disease in Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 22-29.
DOI: 10.14735/amko20153S22.
Keywords: monoclonal antibody – rituximab – ofatumumab – alemtuzumab – obinutuzumab
Authors: Obrtlíková Petra, Urbanová Renata2015-10-15:Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015
Keywords: monoclonal antibody – rituximab – ofatumumab – alemtuzumab – obinutuzumab
Authors: Obrtlíková Petra, Urbanová Renata2015-10-15:Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015
Klin Onkol 2015; 28(Suppl 3): 30-38.
DOI: 10.14735/amko20153S30.
Keywords: chronic lymphocytic leukemia – comorbidity – geriatric assessment – obinutuzumab – rituximab – ofatumumab – ibrutinib – idelalisib
Authors: Smolej Lukáš2015-10-15:Therapeutic Options for „Slow-go“ Patients with Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – comorbidity – geriatric assessment – obinutuzumab – rituximab – ofatumumab – ibrutinib – idelalisib
Authors: Smolej Lukáš2015-10-15:Therapeutic Options for „Slow-go“ Patients with Chronic Lymphocytic Leukemia
Klin Onkol 2015; 28(Suppl 3): 39-44.
DOI: 10.14735/amko20153S39.
Keywords: chronic lymphocytic leukemia – risk factors – deletion 17p – TP53 – transplantation
Authors: Lysák Daniel, Schwarz Jiří2015-10-15:Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations
Keywords: chronic lymphocytic leukemia – risk factors – deletion 17p – TP53 – transplantation
Authors: Lysák Daniel, Schwarz Jiří2015-10-15:Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations
Klin Onkol 2015; 28(Suppl 3): 45-49.
DOI: 10.14735/amko20153S45.
Keywords: chronic lymphocytic leukemia – ibrutinib – idelalisib – rituximab – ABT- 199
Authors: Špaček Jiří2015-10-15:Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future
Keywords: chronic lymphocytic leukemia – ibrutinib – idelalisib – rituximab – ABT- 199
Authors: Špaček Jiří2015-10-15:Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future
Klin Onkol 2015; 28(Suppl 3): 50-54.
DOI: 10.14735/amko20153S50.
Keywords: chronic lymphocytic leukemia – supportive care – infectious complications
Authors: Brejcha Martin2015-10-15:News in the Supportive Care of Chronic Lymphocytic Leukemia
Keywords: chronic lymphocytic leukemia – supportive care – infectious complications
Authors: Brejcha Martin2015-10-15:News in the Supportive Care of Chronic Lymphocytic Leukemia